Structure-Activity Relationships of Inactive-Conformation Binding EGFR Inhibitors: Linking the ATP and Allosteric...

Area of Science:

• Medicinal Chemistry
• Oncology
• Molecular Biology

Background:

• Epidermal growth factor receptor (EGFR) tyrosine kinase is a key target in non-small cell lung cancer (NSCLC).
• Emergence of resistance mutations necessitates development of next-generation EGFR inhibitors.
• Previous research has neglected ATP-competitive inhibitors targeting the EGFR back pocket.

Purpose of the Study:

• To investigate the incorporation of functional groups into an ATP-site imidazole scaffold for EGFR tyrosine kinase inhibitors (TKIs).
• To identify novel binding strategies for overcoming resistance mutations in EGFR-positive NSCLC.

Main Methods:

• Systematic survey of functional groups extending into the EGFR back pocket.
• Design and synthesis of imidazole-based scaffolds with diverse substituents.
• Evaluation of inhibitor potency and structural analysis of binding interactions.

Main Results:

• Meta-substituted amide linkers with fluorine and/or hydroxy groups in the back pocket phenyl demonstrated highest potency.
• Identification of specific binding interactions between functional groups and the EGFR back pocket.
• Demonstrated feasibility of targeting the EGFR back pocket with novel imidazole scaffolds.

Conclusions:

• Novel imidazole-based scaffolds with specific back pocket interactions represent a promising strategy for next-generation EGFR TKIs.
• These findings provide new directions for the discovery and optimization of kinase inhibitors targeting inactive conformations.
• The developed inhibitors show potential for overcoming resistance in EGFR-mutated NSCLC.